Perrigo has entered into an agreement to acquire Naturwohl Pharma and its leading German dietary supplement brand, Yokebe.
“Our acquisition of the margin-enhancing Yokebe brand demonstrates our continued execution on our ‘Base Plus Plus Plus’ strategy by building on Omega Pharma’s leading OTC product portfolio and European commercial infrastructure,” said Perrigo Chairman, President and CEO Joseph C. Papa. “Coupled with our recent acquisition of well-established European brands from GlaxoSmithKline, we continue to leverage our robust balance sheet and strong global platform to execute immediately accretive deals, such as this one, that will have a multiplier effect on our growth.
“With Omega’s pan-European distribution network, strong brand-building capabilities and exceptional management team, Perrigo is uniquely positioned to maximize the potential of these brands to capture an even greater share of the $30 billion European OTC market opportunity.”
Perrigo Company plc is a leading global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API), as well as receives royalties from Multiple Sclerosis drug Tysabri®. The company is the world’s largest manufacturer of OTC pharmaceutical products for the store brand market and an industry leader in pharmaceutical technologies.